Insider Shareholders with Direct Ownership of Viridian Therapeutics, Inc.\De (VRDN)
This section provides a comprehensive overview of the insiders with direct ownership of Viridian Therapeutics, Inc.\De (VRDN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Viridian Therapeutics, Inc.\DE Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Frazier Life Sciences Public Fund, L.P.
> 10% Shareholder |
200,000 | 0 | 1,505,200 $32.4 Million | 1 |
Sep 23, 2021
Added 11.73%
|
|
Logos Global Master Fund Lp
> 10% Shareholder |
476,667 | 0 | 550,000 $11.8 Million | 2 |
Nov 13, 2020
Added 18.72%
|
|
Jonathan Violin
Chief Executive Officer |
677,688 | 200,000 | 430,905 $9.28 Million | 12 |
Feb 02, 2023
Reduced 10.4%
|
|
Scott Dunseth Myers
Chief Executive Officer |
259,500 | 0 | 259,500 $5.59 Million | 3 |
Apr 12, 2023
Added 1.52%
|
|
Lara Meisner
Chief Legal Officer |
59,543 | 89,514 | 29,971 $645,575 | 27 |
Jun 16, 2023
Reduced 0.09%
|
|
Stephen F. Mahoney
President and CEO |
21,400 | 0 | 21,400 $460,956 | 1 |
Sep 27, 2024
Added 50.0%
|
|
Thomas W. Beetham
Chief Operating Officer |
5,000 | 0 | 6,000 $129,240 | 1 |
Sep 27, 2024
Added 45.45%
|
|
Barrett Katz
Chief Medical Officer |
89,000 | 89,000 | 0 $0 | 8 |
Jan 17, 2023
Reduced 100.0%
|